BR0011478A - Composição de combinação imunológica, métodos de induzir uma resposta imunológica em um animal, e de imunizar um hospedeiro contra infecção pneumocócica, e, composição imunogênica para administração intranasal - Google Patents

Composição de combinação imunológica, métodos de induzir uma resposta imunológica em um animal, e de imunizar um hospedeiro contra infecção pneumocócica, e, composição imunogênica para administração intranasal

Info

Publication number
BR0011478A
BR0011478A BR0011478-2A BR0011478A BR0011478A BR 0011478 A BR0011478 A BR 0011478A BR 0011478 A BR0011478 A BR 0011478A BR 0011478 A BR0011478 A BR 0011478A
Authority
BR
Brazil
Prior art keywords
methods
intranasal administration
composition
immunizing
inducing
Prior art date
Application number
BR0011478-2A
Other languages
English (en)
Portuguese (pt)
Inventor
Robert C Huebner
Jacquelyn S Sampson
George M Carlone
Edwin Ades
David E Briles
Original Assignee
Uab Research Foundation
Aventis Pasteur
Ct S For Disease Control And P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uab Research Foundation, Aventis Pasteur, Ct S For Disease Control And P filed Critical Uab Research Foundation
Publication of BR0011478A publication Critical patent/BR0011478A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BR0011478-2A 1999-06-10 2000-06-09 Composição de combinação imunológica, métodos de induzir uma resposta imunológica em um animal, e de imunizar um hospedeiro contra infecção pneumocócica, e, composição imunogênica para administração intranasal BR0011478A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13842299P 1999-06-10 1999-06-10
US58783300A 2000-06-06 2000-06-06
PCT/US2000/040176 WO2000076541A1 (en) 1999-06-10 2000-06-09 Pneumococcal surface protein combination vaccine

Publications (1)

Publication Number Publication Date
BR0011478A true BR0011478A (pt) 2002-03-19

Family

ID=26836182

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0011478-2A BR0011478A (pt) 1999-06-10 2000-06-09 Composição de combinação imunológica, métodos de induzir uma resposta imunológica em um animal, e de imunizar um hospedeiro contra infecção pneumocócica, e, composição imunogênica para administração intranasal

Country Status (7)

Country Link
EP (1) EP1189632A4 (cg-RX-API-DMAC7.html)
JP (1) JP2003519089A (cg-RX-API-DMAC7.html)
AU (1) AU6121000A (cg-RX-API-DMAC7.html)
BR (1) BR0011478A (cg-RX-API-DMAC7.html)
CA (1) CA2379327A1 (cg-RX-API-DMAC7.html)
MX (1) MXPA01012721A (cg-RX-API-DMAC7.html)
WO (1) WO2000076541A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7078042B2 (en) * 1995-09-15 2006-07-18 Uab Research Foundation Pneumococcal surface protein C (PspC), epitopic regions and strain selection thereof, and uses therefor
US20010016200A1 (en) 1998-04-23 2001-08-23 Briles David E. Pneumococcal surface protein C (PspC), epitopic regions and strain selection thereof, and uses therefor
GB0022742D0 (en) * 2000-09-15 2000-11-01 Smithkline Beecham Biolog Vaccine
EP1477802A1 (en) * 2003-05-16 2004-11-17 Erasmus Universiteit Rotterdam Method for selecting and producing vaccine components and vaccines based thereon
JP2010501012A (ja) * 2006-08-17 2010-01-14 ザ ユーエービー リサーチ ファウンデーション 免疫原性ＰｃｐＡポリペプチドおよびその使用
RU2510281C2 (ru) * 2012-06-22 2014-03-27 Общество с ограниченной ответственностью "Эпитоп" (ООО "Эпитоп") ВАКЦИНА ПРОТИВ ПНЕВМОНИИ, ВЫЗЫВАЕМОЙ Streptococcus pneumoniae, НА ОСНОВЕ ГИБРИДНОГО БЕЛКА
GB201318170D0 (en) * 2013-10-14 2013-11-27 Univ Edinburgh Proteins with Diagnostic and Therapeutic Uses
KR101627285B1 (ko) * 2014-06-05 2016-06-07 한국생명공학연구원 ＰｓｐＡ를 유효성분으로 포함하는 퇴행성 뇌질환의 예방 또는 치료용 약학 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5854416A (en) * 1991-11-14 1998-12-29 The United States Of America As Represented By The Department Of Health And Human Services Streptococcus pneumoniae 37-KDA surface adhesin a protein and nucleic acids coding therefor
WO1994014318A1 (en) * 1992-12-24 1994-07-07 Medimmune, Inc. Method of protection against streptococcus pneumoniae with transformed mycobacteria
CA2326408A1 (en) * 1998-03-02 1999-09-10 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Epitope peptides immunogenic against streptococcus pneumoniae
CA2328399A1 (en) * 1998-04-23 1999-10-28 University Of Alabama At Birmingham Pneumococcal surface protein c(pspc), epitopic regions and strain selection thereof, and uses therefor

Also Published As

Publication number Publication date
WO2000076541A1 (en) 2000-12-21
EP1189632A4 (en) 2002-08-21
AU6121000A (en) 2001-01-02
MXPA01012721A (es) 2004-10-14
EP1189632A1 (en) 2002-03-27
JP2003519089A (ja) 2003-06-17
CA2379327A1 (en) 2000-12-21

Similar Documents

Publication Publication Date Title
BRPI0010612B8 (pt) vacinas
BR0113822A (pt) Vacina
BR0009166A (pt) Vacina
NZ507717A (en) Derivatives of pneumococcal choline binding proteins for vaccines
BR0108828A (pt) Formulação de carboidrato (adjuvante pré-biótico) para aperfeiçoamento de resposta imuno
ZA88798B (en) Dental anti-plaque and anti-caries agent
BR0010682A (pt) Novas composições
FI953442A0 (fi) Gonadotropiinia sisältäviä pakastekuivattuja pallosia
MX2008013993A (es) Combinación adyuvante sinergistica de anticuerpo agonista de cd40/interferona tipo 1, conjugados que la contienen y uso de los mismos como un terapeutico para aumentar la inmunidad celular.
PT835133E (pt) Composições recombinantes de poxvírus-raiva e composições de combinação e suas utilizações
HK1043943A1 (zh) 肺炎链球菌蛋白质和疫苗
AU9094191A (en) Recombinant avirulent salmonella antifertility vaccines
EP2275122A3 (en) Protein-based streptococcus pneumoniae vaccines
EP0090581A3 (en) Small peptides with the specificity of foot and mouth disease viral antigens
BR0011478A (pt) Composição de combinação imunológica, métodos de induzir uma resposta imunológica em um animal, e de imunizar um hospedeiro contra infecção pneumocócica, e, composição imunogênica para administração intranasal
WO2001081380A3 (en) Immunogenic pneumococcal protein and vaccine compositions thereof
WO2000058475A3 (en) Streptococcus pneumoniae antigens
CA2139217A1 (en) Vaccine composition for eliciting an immune response against n-glycolylated gangliosides and its use for cancer treatment
EP0775746A3 (en) Coccidiosis poultry vaccine
BG103959A (en) Carbocyclic nucleoside hemisulphate and its application in the treatment of viral infections
AU3172095A (en) Coccidiosis poultry vaccine
AU8467201A (en) Compositions for and methods of using herpes simplex virus glycoprotein d to suppress immune responses
WO2001034184A3 (en) Methods and compositions for protection against bovine herpesvirus 1
MY127452A (en) Vaccines.
BR0114403A (pt) Polipeptìdeos de "haemophilus influenzae" que podem ser usados para fins de profilaxia, diagnóstico e/ou terapia

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A, 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1962 DE 12/08/2008.